Cargando…

Pancreatic Ductal Carcinoma Risk Associated With Hereditary Cancer-Risk Genes

BACKGROUND: Although several hereditary cancer predisposition genes have been implicated in pancreatic ductal adenocarcinoma (PDAC) susceptibility, gene-specific risks are not well defined and are potentially biased because of the design of previous studies. More precise and unbiased risk estimates...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gardiner, Anna, Kidd, John, Elias, Maria C, Young, Kayla, Mabey, Brent, Taherian, Nassim, Cummings, Shelly, Malafa, Mokenge, Rosenthal, Eric, Permuth, Jennifer B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275755/ https://www.ncbi.nlm.nih.gov/pubmed/35445726 http://dx.doi.org/10.1093/jnci/djac069

Ejemplares similares

Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma
por: Chen, Dung-Tsa, et al.
Publicado: (2015)

Cancer Risk Associated With PTEN Pathogenic Variants Identified Using Multigene Hereditary Cancer Panel Testing
por: Cummings, Shelly, et al.
Publicado: (2023)

TGFβ1 overexpression is associated with improved survival and low tumor cell proliferation in patients with early-stage pancreatic ductal adenocarcinoma
por: Glazer, Evan S., et al.
Publicado: (2016)

Case report: Irreversible electroporation for locally advanced pancreatic cancer
por: Orcutt, Sonia, et al.
Publicado: (2017)

Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer
por: Bibok, Andras, et al.
Publicado: (2021)

A Phase I Safety, Pharmacokinetic, and Pharmacodynamic Presurgical Trial of Vitamin E δ-tocotrienol in Patients with Pancreatic Ductal Neoplasia
por: Springett, Gregory M., et al.
Publicado: (2015)

Pancreatic Ductal Adenocarcinoma: Molecular Pathology and Predictive Biomarkers
por: Taherian, Mehran, et al.
Publicado: (2022)

Case Report of Isolated Gastric Metastasis of Pancreatic Cancer From a Diagnostic Biopsy: Management of a Rare Oncologic Entity
por: Rothermel, Luke D., et al.
Publicado: (2020)

Pancreatic cancer risk in hereditary pancreatitis
por: Weiss, Frank U.
Publicado: (2014)

Effect of Metformin Use on Survival in Resectable Pancreatic Cancer: A Single-Institution Experience and Review of the Literature
por: Ambe, Chenwi M., et al.
Publicado: (2016)

Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma
por: Pointer, David T., et al.
Publicado: (2020)

δ-Tocotrienol, a natural form of vitamin E, inhibits pancreatic cancer stem-like cells and prevents pancreatic cancer metastasis
por: Husain, Kazim, et al.
Publicado: (2017)

Comparison of Radiomic Features in a Diverse Cohort of Patients With Pancreatic Ductal Adenocarcinomas
por: Permuth, Jennifer B., et al.
Publicado: (2021)

The impact of age and comorbidity on localized pancreatic cancer outcomes: A US retrospective cohort analysis with implications for surgical centralization
por: Powers, Benjamin D., et al.
Publicado: (2023)

Minimally invasive appendectomy for resection of appendiceal mucocele: Case series and review of the literature
por: Orcutt, Sonia T., et al.
Publicado: (2017)

Targeting the IκB Kinase Enhancer and Its Feedback Circuit in Pancreatic Cancer()
por: Challa, Sridevi, et al.
Publicado: (2020)

Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening
por: Cremin, Carol, et al.
Publicado: (2020)

Pancreatic Ductal Adenocarcinoma: Epidemiology and Risk Factors
por: Ushio, Jun, et al.
Publicado: (2021)

Hospital Surgical Volume Is Poorly Correlated With Delivery of Multimodal Treatment for Localized Pancreatic Cancer: A National Retrospective Cohort Study
por: Powers, Benjamin D., et al.
Publicado: (2022)

Farnesyl dimethyl chromanol targets colon cancer stem cells and prevents colorectal cancer metastasis
por: Husain, Kazim, et al.
Publicado: (2021)

Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors
por: Hall, MacLean, et al.
Publicado: (2016)

Murine Pancreatic Adenocarcinoma Reduces Ikaros Expression and Disrupts T Cell Homeostasis
por: Nelson, Nadine, et al.
Publicado: (2015)

An Overview of Genetic Changes and Risk of Pancreatic Ductal Adenocarcinoma
por: Sarnecka, Agnieszka K., et al.
Publicado: (2016)

Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors
por: Michalak, Natalia, et al.
Publicado: (2023)

Multimodality Management of “Borderline Resectable” Pancreatic Neuroendocrine Tumors: Report of a Single-Institution Experience
por: Ambe, Chenwi M., et al.
Publicado: (2017)

Real time ex vivo chemosensitivity assay for pancreatic adenocarcinoma
por: Kim, Dae Won, et al.
Publicado: (2023)

A Case Control Study of the Seroprevalence of Helicobacter pylori Proteins and Their Association with Pancreatic Cancer Risk
por: Permuth, Jennifer B., et al.
Publicado: (2021)

Combining radiomic features with a miRNA classifier may improve prediction of malignant pathology for pancreatic intraductal papillary mucinous neoplasms
por: Permuth, Jennifer B., et al.
Publicado: (2016)

Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians
por: Piccardi, Margherita, et al.
Publicado: (2023)

A Genome-Wide Investigation of MicroRNA Expression Identifies Biologically-Meaningful MicroRNAs That Distinguish between High-Risk and Low-Risk Intraductal Papillary Mucinous Neoplasms of the Pancreas
por: Permuth-Wey, Jennifer, et al.
Publicado: (2015)

Disparities in Pancreatic Ductal Adenocarcinoma—The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes
por: Riner, Andrea N., et al.
Publicado: (2020)

Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART)
por: Bryant, JM, et al.
Publicado: (2023)

Estimating Metastatic Risk of Pancreatic Ductal Adenocarcinoma at Single-Cell Resolution
por: Chen, Sina, et al.
Publicado: (2022)

Prevalence and Risk Factors of Germline Pathogenic Variants in Pancreatic Ductal Adenocarcinoma
por: Ryu, Kum Hei, et al.
Publicado: (2023)

A pilot study to evaluate tissue- and plasma-based DNA driver mutations in a cohort of patients with pancreatic intraductal papillary mucinous neoplasms
por: Park, Margaret A, et al.
Publicado: (2022)

Epidemiologic risk factors for patients admitted with chronic pancreatitis and pancreatic ductal adenocarcinoma in the United States
por: Lew, Daniel, et al.
Publicado: (2022)

Neurotensin receptors in pancreatic ductal carcinomas
por: Körner, Meike, et al.
Publicado: (2015)

Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes
por: Hu, Chunling, et al.
Publicado: (2018)

Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine
por: Gerber, Michael H., et al.
Publicado: (2018)

Vitamin E δ-tocotrienol sensitizes human pancreatic cancer cells to TRAIL-induced apoptosis through proteasome-mediated down-regulation of c-FLIP(s)
por: Francois, Rony A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1k0jn2uvvnjqdvq92j2erqf1nt